| The Department of Bioscience and Bioengineering is organizing Academia-Industry Discussion Meeting on Curriculum of the Master of Technology (Bioscience and Bioengineering) tentative program schedule at IIT Jodhpur from 29 June - 1 July, 2017. |
Brief profile of profiles of experts :
|
Professor Bishwajit Kundu |
|
| Dr. Bishwajit Kundu, Associate Professor in the Kusuma School of Biological Science, IIT Delhi, received M.Sc. (Biotechnology) from Madurai Kamraj University, Madurai and has earned a Ph.D. degree from IMTECH, Chandigarh. During his doctoral tenure, he worked on Protein Engineering with specialization in protein folding and aggregation. |  |
| He studied the folding behaviour of alpha-crystallins, Carbonic anhydrase and thermostable Xylanases. He then moved to Case Western Reserve University, Cleveland, Ohio, in the department of Physiology & Biophysics as a postdoctoral fellow, and worked on biophysical characterization of human prion proteins. His work on human prions was recognized in the keystone symposium on “Protein folding & diseases” in the year 2002. Dr. Kundu’s by the National Academy of Sciences, USA and was awarded best presentation current interests include rational approaches for designing thermophilic enzymes and studying their biophysical & thermodynamic parameters, with the objective of obtaining therapeutically important proteins. His other interests remain on determining the inherent qualities of peptides and proteins in terms of their interactions & propensities towards aggregation and amyloid formation. | |
|
Professor Dipankar Nandi |
|
| Prof. Dipankar Nandi was born in Kolkata and did his schooling in Mumbai. He was awarded the Ph.D. from the University of California, Berkeley in1991 after completing his B.Sc. (Microbiology) from the University of Bombay in 1983 and M.Sc. (Microbiology) from the M. S. University of Baroda in 1985. |  |
| His doctoral study was on tissue associated T cells and his postdoctoral research at the University of Cincinnati, Ohio was on characterization of proteasomes. His diverse training led him to investigate two broad areas as an independent faculty member since 1997 in the Department of Biochemistry, IISc, Bangalore: host encoded immuneresponses and microbial stress responses and virulence. He enjoys teaching and working closely with motivated students. | |
|
Dr. Rajiv Sharma |
|
| Dr. Rajiv Sharma is the Senior Vice President and Head of Chemistry at Zydus Research Center, Ahmedabad. Dr. Sharma received his Ph.D. in Organic Chemistry from University of Delhi and obtained post-doctorate training in Medicinal Chemistry in National Institutes of Health at Bethesda, Maryland. Prior to Zydus, he has worked in leadership positions at Piramal, Amgen, Tularik and Boehringer Ingelheim. |  |
| His teams have been involved in the discovery of clinical candidates in the fields of oncology, metabolic and inflammatory disorders. He is co-inventor of over 50 patents and coauthor of over 55 articles in peer-reviewed journals. | |
|
Dr. Sharmila Mande |
|
| Dr. Sharmila Mande is Principal Scientist & Head-Biosciences R&D, TCS Innovation Labs, Pune. Her research interests encompass Bioinformatics, Metagenomics, Genome Informatics, Next Generation Sequencing, Algorithms for Biological Data, Disease Informatics and Systems Biology. Dr Sharmila Mande received her Ph.D. in Physics from Indian Institute of Science, Bangalore, India, in 1991. |  |
| She received post-doctoral training at University of Groningen, The Netherlands and University of Washington, Seattle, USA. Dr. Mande has more than 30 years of research experience in the Life Sciences domain. Dr. Mande has contributed significantly to understanding the human microbiome in several diseases and disorders. Dr. Mande has a number of patented algorithms that address challenges faced by researchers in analyzing large-scale biological data. She is a recipient of the TCS Distinguished Scientist Award. | |
|
Dr. Sriram Parameswaran |
|
| Dr. Sriram Parameswaran is Chief Technology Officer at Genotypic Technology,Bangalore. Dr.Parameswaran leads the technology functions across Microarrays, Next Generation Sequencing and Molecular assays. Dr.Parameswaran provides strategic, scientific and technical inputs to projects enabling effective application of technology to solve client requirements. |  |
| Prior to Genotypic Technology, he has worked in leadership & Research positions at Monsanto, DuPont and Reliance. Dr.Parameswaran received B.Sc. (Honours) Biochemistry from University of Delhi and has earned a Ph.D. degree from IISc, Bangalore. | |
|
Dr. Arun Balakrishnan |
|
| Dr. Arun Balakrishnan is Chief Scientific Officer with a rich academic, research and business background. Dr. Balakrishnan heads OmniActive’s R&D efforts. He is primarily responsible for establishing processes for quick turnaround of projects driven by customer needs, developing delivery platforms and improving existing products.Lifesciences. |  |
| Dr. Balakrishnan has held positions as a Professor/Researcher at the Centre for Biotechnology, Anna University, Chennai and as Senior Vice President for Screening and External Liaison of the Natural Products division at Piramal. He holds a Bachelor’s of Science in Chemistry and a Master’s and Ph.D. in Biochemistry from the University of Madras. Additionally, he served for 4 years as a postdoctoral research associate at the University of California, Berkeley. | |
|
Dr. Taslimarif Saiyed |
|
| Dr. Taslimarif Saiyed is the Director and COO of C-CAMP, Centre for Cellular and Molecular Platforms. In this role, he manages C-CAMP's technology platforms, growth strategies, strategic collaborations for new technology creation, education and training programmes, business and innovation accelerator unit. |  |
| He also oversees the Intellectual Property and Technology Transfer Office at C-CAMP.Prior to joining C-CAMP, he worked as a Scientist with University of California, San Francisco (UCSF), studying neurodegenerative diseases like Parkinson's disease. He holds a doctorate in Neuroscience from Max-Planck Institute for Brain Research, Germany. In the bay area, he also served as a Management Consultant with QB3 New Biotech Venture Consulting as well as in an individual capacity where he consulted for biotech firms in the US. | |
|
Dr. Kuldeep Singh |
|
| Dr. Kuldeep Singh is Professor and Head, Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur. He is MBBS (1988), MD (Pediatrics- KGMC, Lucknow), DM (Medical Genetics-SGPGI, Lucknow, India). He enjoys Teaching (MBBS students), Training (medical students, residents and health staff) and Research (as Principal investigator, co-investigator, co-guide and support). His field of interest is Pediatrics, Medical Genetics, Medical Education, Digital Approach in teaching. |  |
|
Satyendra Johri |
|
| Mr. Satyendra Johri is Chariman & Managing Director at Johari Digital Healthcare Ltd. Mr Johari laid a solid foundation of electro-medical device manufacturing. He started in a garage and has now developed 45000+ sq. facility, which is audited by FDA USA health ministry for GMP (Good Mfg Practice). Have many FDA 510(k) clearances, IPs,CE,UL,CMD CAS,TGA. |  |
| Mr Johri has a Bachelor of Engineering (Hons.) in Electrical and Electronics Engineering from Birla Institute of Technology and Science and a Master’s degree in Finance from West Coast University. | |
|
Dr. Shilpi Gupta Dixit |
|
| Dr. Shilpi Gupta Dixit is Associate Professor in Department of Anatomy, All India Institute of Medical Sciences, Jodhpur. She is MBBS (2001), MD (Anatomy, Delhi University, 2006) and DNB Anatomy (2007). |  |
Please click here for tentative program schedule of the meeting.
